Diabetic foot (diabetes mellitus) is a general description for the range of foot problems in patients with diabetes and develops from a variety of causes.

Diabetes affects the feet in a substantial way, by damaging blood vessels, impairing the immune system and frequently causing a tendency to delayed wound healing. Infection of the foot is relatively common. Most significantly up to fifteen percent of diabetics patients develop foot ulcers at some time in their lives. Difoprev is specifically designed to treat this condition.

Foot related problems are responsible for up to 50% diabetes related hospital admissions.

There are 5,000 amputations per year in the UK due to diabetes.

Diabetic foot ulcer is one of the most significant complications of diabetic foot; it occurs in 15% of all diabetes patients and proceeds over 80% of all lower leg amputations. Difoprev is specifically designed to treat this condition.

In simple terms peripheral neuropathy causes a loss of pain and feeling in the toes, and feet due to nerve damage and low blood flow. Blisters and sores appear on the numb areas of the feet and heels and as a result of pressure or even injury are unnoticed and this eventually becomes a portal of entry for bacteria and infection.

Good foot care combined with increased and regular examination of the feet can reduce the incidence of serious foot lesions. Difoprev can be an important part of a diabetic foot care regime.

Some results of treatment from trials of Difoprev